| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-21 |
4 |
B |
$1.64 |
$53,411 |
I/I |
32,556 |
30,611,915 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-22 |
4 |
B |
$1.67 |
$13,859 |
I/I |
8,307 |
30,620,222 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-23 |
4 |
B |
$1.71 |
$149,240 |
I/I |
87,500 |
30,707,722 |
0.01 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-04 |
4 |
S |
$0.31 |
$12,867 |
I/I |
(41,399) |
921,557 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-05 |
4 |
S |
$0.30 |
$3,216 |
I/I |
(10,670) |
910,887 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-06 |
4 |
S |
$0.30 |
$11,448 |
I/I |
(37,931) |
872,956 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-08 |
4 |
S |
$0.24 |
$8,320 |
I/I |
(35,000) |
1,602,956 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-19 |
4 |
S |
$0.21 |
$7,430 |
I/I |
(36,000) |
1,566,956 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-20 |
4 |
S |
$0.20 |
$7,200 |
I/I |
(36,000) |
63,789 |
0 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2024-05-23 |
4 |
OE |
$0.00 |
$0 |
I/I |
86,960 |
30,794,682 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
798,767 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,886,590 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-02 |
4 |
B |
$9.48 |
$40,764 |
D/D |
4,300 |
2,890,890 |
2.37 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-04 |
4 |
B |
$9.04 |
$1,808,260 |
D/D |
200,000 |
3,090,890 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-05 |
4 |
B |
$4.50 |
$525,000 |
D/D |
110,000 |
3,200,890 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-06 |
4 |
B |
$3.90 |
$610,100 |
D/D |
154,000 |
3,354,890 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-09 |
4 |
B |
$3.60 |
$626,615 |
D/D |
151,782 |
3,506,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-13 |
4 |
B |
$10.00 |
$250,000 |
D/D |
25,000 |
3,531,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-04 |
4 |
B |
$3.66 |
$146,260 |
D/D |
40,000 |
3,571,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-05 |
4 |
B |
$3.71 |
$122,791 |
D/D |
33,100 |
3,604,772 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-08 |
4 |
B |
$3.80 |
$60,754 |
D/D |
16,000 |
3,620,772 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-09 |
4 |
B |
$3.77 |
$100,984 |
D/D |
26,789 |
3,647,561 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-10 |
4 |
B |
$3.75 |
$149,952 |
D/D |
40,000 |
3,687,561 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-11 |
4 |
B |
$3.64 |
$46,289 |
D/D |
12,700 |
3,700,261 |
2.37 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-12 |
4 |
B |
$3.74 |
$69,293 |
D/D |
18,518 |
3,718,779 |
2.45 |
- |
|
634 Records found
|
|
Page 5 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
